XML 24 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 928,438 $ 1,136,438 $ 1,004,356
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation expense 816,965 814,978 758,596
Amortization of deferred financing costs and debt discount 12,732 11,218 10,143
Loss on extinguishment of debt, net 150 1,646 17,787
Amortization of stock-based compensation 27,142 33,864 25,505
Equity in loss (income) of, and return on, unconsolidated investments and noncontrolling interests, net of eliminations 5,332 5,255 (108)
Casualty loss 4,622 0 1,723
Abandonment of development pursuits 33,479 5,599 685
Unrealized gain on terminated cash flow hedges 0 0 (2,654)
Cash flow hedge losses reclassified to earnings 1,360 3,883 7,887
Gain on sale of real estate assets (287,987) (600,958) (630,747)
Increase (decrease) in prepaid expenses and other assets 5,777 (7,167) 5,505
Increase in accrued expenses, other liabilities and accrued interest payable 12,019 17,176 4,492
Net cash provided by operating activities 1,560,029 1,421,932 1,203,170
Cash flows from investing activities:      
Development/redevelopment of real estate assets including land acquisitions and deferred development costs (901,847) (921,203) (654,861)
Acquisition of real estate assets (215,889) (536,838) (771,692)
Capital expenditures - existing real estate assets (178,312) (160,313) (142,688)
Capital expenditures - non-real estate assets (18,962) (14,392) (10,547)
Increase (decrease) in payables for construction 14,901 9,080 (29,887)
Proceeds from sale of real estate and for-sale condominiums, net of selling costs 467,096 1,051,383 974,762
Note receivable lending (82,802) (29,352) (1,210)
Note receivable payments 253 4,021 2,435
Distributions from unconsolidated entities 5,468 51,464 63,171
Unconsolidated investments (18,861) (14,269) (53,536)
Net cash used in investing activities (928,955) (560,419) (624,053)
Cash flows from financing activities:      
Issuance of common stock, net 496,706 20,020 31,874
Repurchase of common stock, net (1,911) 0 0
Dividends paid (922,657) (889,607) (888,344)
Repayments of mortgage notes payable, including prepayment penalties (47,000) (43,332) (109,562)
Issuance of unsecured notes 399,756 348,565 1,098,643
Repayment of unsecured notes (750,000) (100,000) (462,147)
Payment of deferred financing costs (3,964) (14,301) (8,864)
Receipt for termination of forward interest rate swaps 8,331 26,869 4,751
Payments related to tax withholding for share-based compensation (10,639) (16,989) (13,463)
Noncontrolling interests, joint venture and preferred equity transactions (2,981) (2,281) (1,749)
Net cash used in financing activities (834,359) (671,056) (348,861)
Net (decrease) increase in cash, cash equivalents and restricted cash (203,285) 190,457 230,256
Cash, cash equivalents and restricted cash, beginning of year 734,245 543,788 313,532
Cash, cash equivalents and restricted cash, end of year 530,960 734,245 543,788
Cash paid during the year for interest, net of amount capitalized 187,523 212,241 203,773
Supplemental Cash Flow Information      
Cash and cash equivalents 397,890 613,189 420,251
Restricted cash 133,070 121,056 123,537
Cash, cash equivalents and restricted cash reported in the Consolidated Statements of Cash Flows $ 530,960 $ 734,245 $ 543,788